American Pharma Holdings
Manufacturing · Lobbying Client
C
Influence Score
40/100
Moderate Influence
$1.1M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door
American Pharma Holdings reported $1.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Manufacturing, Taxation, Trade. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Commerce
US Senate
Securities & Exchange Commission
Food & Drug Administration
Federal Aviation Administration
Dept of Transportation
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Squire Patton Boggs LLP | TRD | 1 | $80K |
| 2020 Apr-Jun | BGR Group LLP | GOVTAXMAN+1 | 1 | $86K |
| 2020 Jul-Sep | Holland & Knight LLP | TRDMAN | 1 | $69K |
| 2020 Oct-Dec | Cassidy & Associates LLP | TRDMANTAX+1 | 1 | $65K |
| 2021 Jan-Mar | BGR Group LLP | GOVTAXMAN+1 | 1 | $54K |
| 2021 Apr-Jun | Squire Patton Boggs LLP | TAXGOVTRD | 1 | $49K |
| 2021 Jul-Sep | Cassidy & Associates LLP | GOV | 1 | $37K |
| 2021 Oct-Dec | BGR Group LLP | TRDTAXGOV | 1 | $34K |